Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)

16.26
Delayed Data
As of Jul 31
 +0.51 / +3.24%
Today’s Change
8.71
Today|||52-Week Range
18.30
+40.05%
Year-to-Date
No recent news for Amphastar Pharmaceuticals Inc.

Today’s Trading

Previous close15.75
Today’s open15.82
Day’s range15.67 - 16.32
Volume209,584
Average volume (3 months)338,164
Market cap$704.4M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-180.65%
Earnings growth (this year)-203.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.37%
P/E ratioNM
Price/Sales2.31
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...+0.44+2.19%
SRNESorrento Therapeutic...+0.39+1.91%
OMEDOncoMed Pharmaceutic...+1.16+5.35%
RVNCRevance Therapeutics...-0.83-2.61%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$210.5M
Annual profit (last year)-$10.7M
Net profit margin-5.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, COO &
Chief Scientist
Zi Ping Luo
Director, Chief Executive &
Science Officer
Yongfeng Zhang
Corporate headquarters
Rancho Cucamonga, California

Forecasts